Xin Zhou Lab newsroom
Science in motion.
Stories with impact.
Lab milestones, research advances, and selected media coverage from our work in precision microbiome science, longitudinal multi-omics, and intelligent medicine.
In the spotlight
Featured Media
Latest reporting and interviews featuring the lab’s work.
Inside the lab
Lab News
Research progress, appointments, and milestones from the Xin Zhou Lab and its collaborators.
Xin Zhou elected as an IFPMA Task Force Expert for the ICH E24 Expert Working Group
On June 10, 2026, Xin Zhou was elected as an International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) Task Force Expert supporting the ICH E24 Expert Working Group. The group focuses on natural history studies and registry data to advance rare disease drug development.
Designing microbiome studies that can be reproduced
Our review in Med examines statistical power and sample-size estimation across human microbiome study designs, emphasizing simulation-based planning and realistic pilot data.
AI-enabled microbiome and multi-omics research advances
New work in The Lancet Microbe, Med, Molecular Omics, and Microbiome advances experimental design, AI-enabled analysis, and cross-body-site multi-omics.
Xin Zhou appointed Executive Associate Director at the PolyU–Stanford Joint Research Center
In November 2025, Xin Zhou was appointed Executive Associate Director at the Hong Kong PolyU–Stanford Joint Research Center. The role is to lead a research program on digital twin related to aging and human health.
Xin Zhou establishes the laboratory at Fudan University
Xin Zhou began serving as a tenure-track Principal Investigator at the Intelligent Medicine Institute, Fudan University, alongside a Professor appointment at the Hong Kong PolyU–Stanford Joint Research Center.
Broadening precision-medicine applications
Lab publications addressed pulmonary arterial hypertension, core microbiome signatures, precision medicine, antimicrobial resistance, and AI-enabled healthcare.
Personal microbiomes remain uniquely stable over time
A six-year, multi-body-site study showed that the most individualized features of a person’s microbiome are often the most stable, generating broad international media coverage.
Press & features
Media Reports
Profiles and reporting featuring the lab’s research.
